Search Results
Results found for "Neel Freedman"
- How GPCR Collaboration Built an Innovation Engine
project-level thinking to platform-level strategy — a critical shift for GPCR biology, where complex systems need Collaboration isn’t a feel-good story.
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
"When you talk to patients that have an unmet need, you learn things that no one is thinking about in how personal pain can lead to professional purpose — and why the next generation of pain researchers needs
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
Takeaway We don’t need better in vitro data — we need better models of reality. Dr.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Don't let misconceptions about receptor binding kinetics slow your progress—gain the clarity you need Our weekly curated news and expert frameworks provide the actionable intelligence you need to make sense GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need Don’t Fall Behind—Access the Edge You Need 👉 Become a Premium Member Today ➤ Already a Premium Member Gain the insights, tools, and connections you need to excel in your field and make your mark.
- Molecular creativity in drug discovery
GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need GPCR the best for the sake of promoting more educational opportunities that are sorely needed in the
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Freeman BB, 3rd, Yang L, Rankovic Z. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
If you need to brief leadership, plan experiments, or time a move in the market or your career, Premium GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need Kenakin is a masterful teacher and communicator." — DrGPCR University Attendee Everything you need to
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
re stuck trying to figure out why your lead compound looks promising in vitro but flops in vivo, you need
- Pharmacology Isn't What You Think—It's So Much More
contradictory This lesson isn’t just academic—it’s practical knowledge every early-stage scientist needs
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
It’s a response to unmet scientific needs: Replace microscopy-heavy workflows with no-wash, live-cell Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists actually need—and GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Fluorescent ligands based on small molecules bind to the functional sites of receptors in live cells, no need No need for fixation and permeabilization This step can modify receptor conformation and affect downstream Compatibility with live cells No need for fixation of permeabilization.
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Power analysis tells you exactly how many replicates you need for 95% confidence. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization Tool Designed for Real Research Needs s of GPCR assay innovation , pHSense™ was developed to overcome
- Fluorescence Polarization in GPCR Research
Fluorescence Polarization (FP) is especially useful since it allows real time detection and there is no need This means no washing steps are needed to reduce background signal. Figure 1. Unlike other techniques (FRET-based), only one fluorophore is needed.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
week: high-impact insight into GPCR allostery, crafted for pharmacologists and biotech scientists who need Why you need to be there: Learn how kinetic nuance shapes ligand design. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need
- Adhesion GPCR Consortium Newsletter - May 2024
The excitement I felt when I first attended back in Boston is the same one I feel now that I am the organizer historically excluded demographics are finally included, this represents a building block to reinforce the need Mariachi song: I typically do not sing to these since they are dear to Mexican childhood memories, and I feel
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
technical overview, this is a story of curiosity, persistence, and using science to meet unmet clinical needs publish or patent; it was to bring a novel, safer class of pain therapeutics to patients — an urgent need Whether it's chronic pain, addiction, or another unmet need, keeping the real-world impact in focus can
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
First responders describe revivals that don’t feel like revivals, as if the body is still trapped in those pathways, her research gives scientists, first responders, and policymakers the knowledge they need
- Accelerating GPCR Drug Discovery
Traditional roles rarely gave me the freedom to implement these changes at the scale needed. conversations keep me on the front lines, sharpening my understanding of the common bottlenecks and evolving needs
- Knowing When to Walk, Knowing When to Run: Lessons from the Bench
Other times, you’ll need to sprint. Knowing the difference is survival.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
, and system sensitivity to surface mechanism—before you lock in a screen that hides the signal you need translational pharmacologists, biotech discovery teams, platform company leaders, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
incorporating kinetic modeling early in your pipeline, ensuring your candidates have the persistence needed GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
Building for the Future The Sakmar lab built a system to meet that need: Dual-epitope tagged constructs
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
. 👉 Email us to chat, collaborate and tell us what you need ➤ Terry’s Corner—Basic Pharmacokinetics GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ 👉 Already a To succeed, you need to move beyond standard approaches and adopt the frameworks that are driving real
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
This emphasis may have caused other signaling pathways to be overlooked due to a need for adequate assay aberrant ERK activity can lead to uncontrolled cell proliferation and survival, highlighting the pressing need This further underscores the need for advanced assay technologies and a deep understanding of cellular
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
classic models of Schild and Gaddum continue to inform modern analysis, while also highlighting the need topics Who it’s for: drug discovery teams, pharmacologists refining their toolkit, and scientists who need
- Canonical chemokine receptors as scavenging “decoys”
continuously migrate by remaining responsive to chemokines, it dampens the inflammatory response when needed implications of its inhibition, an in-depth understanding of the underlying regulatory mechanisms is needed
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
a disease where novel interventions that move beyond dopamine receptor antagonists are desperately needed While more work is needed to further elucidate the translational value of selectively targeting CB2 receptors



























